Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ISM”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Large-scale testing (Phase 3)UnknownNCT05084872
What this trial is testing

Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients

Who this might be right for
Mastocytosis
University Hospital, Toulouse 30
Early research (Phase 1)Study completedNCT02808793
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002

Who this might be right for
Indolent Systemic Mastocytosis
Allakos Inc. 25
Testing effectiveness (Phase 2)UnknownNCT01920204
What this trial is testing

Midostaurin in Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
University Medical Center Groningen 20
Testing effectiveness (Phase 2)Study completedNCT02086786
What this trial is testing

Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 70
Large-scale testing (Phase 3)Study completedNCT00814073
What this trial is testing

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
AB Science 135
Early research (Phase 1)Study completedNCT03401320
What this trial is testing

Evaluation of IM Letrozole ISM® Pharmacokinetics, Safety, and Tolerability in Healthy Post-menopausal Women (LISA-1)

Who this might be right for
Healthy
Rovi Pharmaceuticals Laboratories 53
Testing effectiveness (Phase 2)Study completedNCT02478957
What this trial is testing

Treatment of Indolent Systemic Mastocytosis With PA101

Who this might be right for
MastocytosisSystemic MastocytosisIndolent Systemic Mastocytosis
Patara Pharma 41
Not applicableLooking for participantsNCT07255638
What this trial is testing

A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

Who this might be right for
Indolent Systemic Mastocytosis
Blueprint Medicines Corporation 80
Not applicableLooking for participantsNCT07264959
What this trial is testing

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

Who this might be right for
Indolent Systemic Mastocytosis
Blueprint Medicines Corporation 150
Not applicableStudy completedNCT03742648
What this trial is testing

The Effectiveness of Deep Breathing Exercises and Incentive Spirometry in Second Degree Inhalation Burn Patients

Who this might be right for
Burn Patients
Isra University 30
Post-approval studies (Phase 4)Looking for participantsNCT06748001
What this trial is testing

Avapritinib Rollover Study

Who this might be right for
Mastocytosis, Systemic
Blueprint Medicines Corporation 60
Early research (Phase 1)Study completedNCT01788774
What this trial is testing

Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths

Who this might be right for
SchizophreniaSchizoaffective Disorder
Rovi Pharmaceuticals Laboratories 36
Early research (Phase 1)Study completedNCT01320410
What this trial is testing

Pharmacokinetics, Safety, and Tolerance Study of Single Dose Administration of Risperidone ISM®

Who this might be right for
Healthy
Rovi Pharmaceuticals Laboratories
Not applicableStudy completedNCT02620254
What this trial is testing

Mast Cell Connect: A Registry for Patients With Mastocytosis

Who this might be right for
Mastocytosis
Blueprint Medicines Corporation 743
Testing effectiveness (Phase 2)Active Not RecruitingNCT05186753
What this trial is testing

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Who this might be right for
SSMMastocytosis, IndolentMastocytosis, Systemic+5 more
Cogent Biosciences, Inc. 237
Not applicableUnknownNCT05923372
What this trial is testing

Evaluation of the DALY on a Cohort of Patients With Indolent Systemic Mastocytosis

Who this might be right for
Mastocytosis, Indolent Systemic
University Hospital, Toulouse 160
Not applicableStudy completedNCT05480046
What this trial is testing

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 275
Very early researchUnknownNCT05043701
What this trial is testing

Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Oslo University Hospital 15
Not applicableStudy completedNCT07335549
What this trial is testing

Istmin Levels in Laparoscopik Sleeve Gastrectomy

Who this might be right for
Obesity & OverweightSleeve GastrectomyAdipokines
Saglik Bilimleri Universitesi 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03731260
What this trial is testing

(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
Blueprint Medicines Corporation 251
Load More Results